Maria D. Chermá | Medicine and Health Sciences | Best Researcher Award

Published on by Innovation Technologist

Best Researcher Award

Maria D. Chermá
Linköping University, Sweden

Maria D. Chermá
Affiliation Linköping University
Country Sweden
Scopus ID 6507872208
Documents 13
Citations 181
h-index 8
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards
ORCID 0000-0003-0209-9967

Maria D. Chermá is a researcher associated with the Swedish academic and forensic science research environment. Her publication record reflects contributions to forensic toxicology, analytical chemistry, pharmacokinetics and the investigation of drug metabolism. Her research addresses scientific questions relevant to the detection, interpretation and evaluation of substances in biological specimens. Her documented publications and bibliometric indicators provide the foundation for recognition under the Best Researcher Award category.

Abstract

This academic recognition profile presents Maria D. Chermá’s research activities in medicine and health sciences, with particular emphasis on forensic toxicology and pharmacokinetic investigations. Her scholarly work includes studies examining anabolic androgenic steroids, zopiclone and oxycodone. These subjects demonstrate the relevance of analytical measurement and drug metabolism research to forensic interpretation and public health. The profile considers publication contributions, research visibility and documented academic indicators in relation to the Best Researcher Award.

Keywords

Forensic toxicology; pharmacokinetics; analytical chemistry; drug metabolism; mass spectrometry; substance use; medicine and health sciences; biological specimens; toxicological analysis.

Introduction

Forensic toxicology contributes to healthcare, criminal investigations and scientific understanding of substance exposure. Reliable identification and interpretation of drugs and their metabolites require validated analytical approaches and knowledge of pharmacokinetic processes. Chermá’s identified publications address these interconnected areas through investigations involving biological samples and drug-related measurements. Her work illustrates the importance of combining laboratory research with scientifically supported interpretation of toxicological findings.[3][4]

Research Profile

Her research profile is associated with analytical and forensic investigations of pharmaceutical and other substances. The supplied bibliometric information records 13 documents, 181 citations and an h-index of 8. These indicators offer quantitative perspectives on publication activity and citation visibility. They should be interpreted alongside research quality, methodological relevance, individual contributions and the scientific significance of published findings. Her ORCID identifier provides an additional means of distinguishing her scholarly record.[1][2]

Research Contributions

The identified research themes include:

  • Investigation of anabolic androgenic steroid use within a Swedish forensic population.
  • Pharmacokinetic evaluation of zopiclone and metabolite-to-parent ratios for estimating intake timing.
  • Examination of oxycodone pharmacokinetics and its phase I and phase II metabolites using LC–MS-MS.

Together, these topics demonstrate the importance of analytical toxicology in understanding substance exposure, metabolism and evidence interpretation.[3][4][5]

Publications

Three identified publications illustrate the breadth and continuity of her research interests:

  1. Use of anabolic androgenic steroids in a Swedish forensic population: Associations with substance use and criminal convictions. Drug and Alcohol Dependence, October 2026.
  2. Blood pharmacokinetics and use of metabolite-to-parent ratios to predict time of last zopiclone intake. Journal of Analytical Toxicology, 2026.[4]
  3. Urinary Pharmacokinetics of Immediate and Controlled Release Oxycodone and its Phase I and II Metabolites Using LC–MS-MS. Journal of Analytical Toxicology, 2022.[5]

Research Impact

The reported 181 citations and h-index of 8 indicate measurable scholarly visibility. The publication topics also connect laboratory-based research with practical forensic applications, particularly drug identification, exposure assessment and interpretation of biological measurements. Such contributions are relevant to the continuing development of analytical methods and evidence-based toxicological practice. Citation indicators provide useful context but do not independently establish research quality or societal impact.

Award Suitability

Maria D. Chermá’s documented research themes, publication activity and reported citation indicators provide relevant considerations for the Best Researcher Award under the Medicine and Health Sciences category. Her work addresses scientifically important questions in forensic toxicology and pharmacokinetics. The Global Innovation Technologist Awards recognize research contributions, scholarly development and the advancement of knowledge across disciplines. Final award assessment should consider verified authorship, individual research responsibilities and the applicable evaluation criteria.

Conclusion

Maria D. Chermá’s academic profile reflects research engagement in forensic toxicology, analytical chemistry and pharmacokinetic science. Her identified publications address drug metabolism and toxicological investigations with relevance to medicine and forensic applications. The reported bibliometric indicators and documented research themes establish a foundation for consideration in the Best Researcher Award category of the Global Innovation Technologist Awards. Her profile represents the contribution of analytical research to scientific understanding and evidence-based practice.

References

  1. Elsevier. (n.d.). Scopus author details: Maria D. Chermá, Author ID 6507872208. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=6507872208
  2. ORCID. (n.d.). Maria D. Chermá: ORCID researcher identifier.
    https://orcid.org/0000-0003-0209-9967
  3. Chermá, M. D., et al. (2026). Use of anabolic androgenic steroids in a Swedish forensic population: Associations with substance use and criminal convictions. Drug and Alcohol Dependence.
    https://doi.org/10.1016/j.drugalcdep.2026.113410
  4. Gomonit, M. M., Nilsson, G. H., Nyström, I., Berglund, L., Kugelberg, F. C., Chermá, M. D., et al. (2026). Blood pharmacokinetics and use of metabolite-to-parent ratios to predict time of last zopiclone intake. Journal of Analytical Toxicology, 50(6).
    https://doi.org/10.1093/jat/bkag032
  5. Truver, M. T., Jakobsson, G., Chermá, M. D., Swortwood, M. J., Gréen, H., & Kronstrand, R. (2022). Urinary Pharmacokinetics of Immediate and Controlled Release Oxycodone and its Phase I and II Metabolites Using LC–MS-MS. Journal of Analytical Toxicology, 46(9), 1025–1031.
    https://doi.org/10.1093/jat/bkab123
  6. National Library of Medicine. (2026). Blood pharmacokinetics and use of metabolite-to-parent ratios to predict time of last zopiclone intake.

Jun Hu | Medicine and Health Sciences | Best Researcher Award

Published on by Innovation Technologist

Best Researcher Award

Jun Hu
The First Affiliated Hospital of Shantou University Medical College, China

Jun Hu
Affiliation The First Affiliated Hospital of Shantou University Medical College
Country China
Scopus ID 55712134300
Documents 39
Citations 651
h-index 15
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards
ORCID 0000-0002-1864-4862

Jun Hu is a medical researcher affiliated with The First Affiliated Hospital of Shantou University Medical College, China. His reported scholarly record includes 39 documents, 651 citations and an h-index of 15. These bibliometric indicators provide a quantitative overview of publication activity and citation visibility. His documented publications address clinical questions involving knee osteoarthritis, disparities in treatment outcomes and serious bacterial infections. The Best Researcher Award profile highlights these research contributions within the Medicine and Health Sciences subject area.

Abstract

This academic recognition profile summarizes Jun Hu’s reported research metrics and two 2026 journal articles concerning musculoskeletal health disparities and severe infectious disease. The publications illustrate distinct clinical research themes, including differences in pain and arthroplasty outcomes across racial groups and case-based reporting of group A β-hemolytic streptococcal infection associated with purpura fulminans. Bibliometric figures are presented as supplied and should be checked against the current Scopus author record. [1] [2]

Keywords

Jun Hu; Best Researcher Award; clinical research; medicine; health sciences; knee osteoarthritis; total knee arthroplasty; racial disparities; group A β-hemolytic streptococcus; purpura fulminans; bibliometrics.

Introduction

Medical research contributes to evidence-based practice by examining disease patterns, clinical outcomes and challenges affecting patient care. Research on osteoarthritis can help clarify variation in pain and access to joint replacement, while infectious disease case reports can document serious presentations that warrant clinical attention. Hu’s supplied publication records represent these complementary areas of investigation. The available information supports a focused account of the named studies but does not establish their individual methods or findings beyond the bibliographic details provided. [2] [3]

Research Profile

Hu’s reported scholarly profile comprises 39 documents, 651 citations and an h-index of 15. Together, these indicators describe publication volume, citation activity and a balance of productivity and citation reach. They should be interpreted alongside research quality, authorship contributions, methodological rigor and clinical relevance rather than as standalone measures of merit. His listed affiliation provides institutional context for the recognition profile. The supplied records do not establish a comprehensive account of his research appointments, specialist training or leadership responsibilities.

Research Contributions

The two supplied publications identify different clinical questions. The osteoarthritis article explicitly addresses racial disparities in pain and total knee arthroplasty across disease phenotypes. The infectious disease article reports two cases involving group A β-hemolytic streptococcus and purpura fulminans. Considered together, these topics concern both variation in musculoskeletal care and the documentation of severe infection. Their precise implications require interpretation of the full articles, including study design, results, limitations and clinical context. [2] [3]

Publications

  1. “Racial disparities in pain and total knee arthroplasty across knee osteoarthritis phenotypes.” Frontiers in Aging, published 20 May 2026. [2]
  2. “Group A β-hemolytic streptococcus causing purpura fulminans: two case reports.” Frontiers in Immunology, published 10 February 2026. [3]

Research Impact

The reported citation count and h-index indicate measurable scholarly visibility, although citation totals vary over time and across databases. The listed articles address subjects relevant to clinical research and patient care. A robust assessment of impact would additionally examine citation context, independent uptake, methodological quality, reproducibility and evidence of influence on clinical practice. No specific patient outcomes or changes to medical guidelines can be inferred from the bibliographic information alone. [1]

Award Suitability

The supplied publication record and bibliometric indicators provide relevant material for consideration under the Best Researcher Award at the Global Innovation Technologist Awards. A balanced evaluation should consider originality, the nominee’s verified contribution to each publication, research integrity, clinical relevance and independent evidence of impact. This profile summarizes submitted information and does not itself constitute independent verification or confirmation of an award decision.

Conclusion

Jun Hu’s reported research profile combines established bibliometric indicators with publications addressing osteoarthritis-related disparities and severe bacterial infection. These records provide a basis for reviewing his scholarly activity in medicine and health sciences. Verification of author identity, publication attribution and current citation data remains important for a complete and transparent recognition assessment.

References

  1. Elsevier. (n.d.). Scopus author details: Jun Hu, Author ID 55712134300. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=55712134300
  2. Frontiers. (2026). Racial disparities in pain and total knee arthroplasty across knee osteoarthritis phenotypes. Frontiers in Aging. DOI: 10.3389/fragi.2026.1819274.
    https://doi.org/10.3389/fragi.2026.1819274
  3. Frontiers. (2026). Group A β-hemolytic streptococcus causing purpura fulminans: two case reports. Frontiers in Immunology. DOI: 10.3389/fimmu.2026.1659910.
    https://doi.org/10.3389/fimmu.2026.1659910
  4. ORCID. (n.d.). Jun Hu: ORCID researcher identifier.
    https://orcid.org/0000-0002-1864-4862
  5. Global Innovation Technologist Awards. (n.d.). Official award website.
    innovationtechnologist.com

Mercedes Cao Vilariño | Medicine and Health Sciences | Research Excellence Award

Published on by Innovation Technologist

Research Excellence Award

Mercedes Cao Vilariño
Universitary Hospital, Spain

Mercedes Cao Vilariño
Affiliation Universitary Hospital
Country Spain
Scopus ID 57195055799
Documents 5
Citations 15
h-index 3
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards

Mercedes Cao Vilariño is a researcher associated with medical and health sciences in Spain. Her documented research includes a 2020 publication examining smoking cessation support and carbon monoxide monitoring among kidney transplant patients who smoke. This article presents a research profile and recognition overview for the Research Excellence Award associated with the Global Innovation Technologist Awards. The available bibliographic information and supplied research metrics provide the basis for this summary; further verification is needed to establish a comprehensive publication record and award decision.

Abstract

This profile summarizes the supplied academic indicators and a reported clinical research publication associated with Mercedes Cao Vilariño. The study concerns a randomized clinical trial investigating carbon monoxide monitoring using CO-oximetry and brief anti-smoking advice for kidney transplant recipients who smoke. The topic connects preventive healthcare, tobacco cessation, and the management of health risks in transplant populations. Supplied bibliometric figures list five documents, 15 citations, and an h-index of three; these values should be interpreted according to the source and date of retrieval. [1] [2]

Keywords

Mercedes Cao Vilariño; medicine and health sciences; kidney transplantation; smoking cessation; CO-oximetry; clinical research; preventive medicine; research impact; research excellence.

Introduction

Research excellence in healthcare involves the systematic investigation of clinical questions, evaluation of evidence, and potential translation of findings into practice. Smoking cessation is particularly relevant to patients with complex medical histories, including kidney transplant recipients. Research into brief interventions and objective monitoring methods may inform approaches to identifying tobacco use and supporting cessation. The listed publication provides a specific bibliographic point of reference for understanding this research area. [1]

Research Profile

The supplied profile associates the researcher with a hospital institution in Spain and the subject area of medicine and health sciences. The Scopus author identifier provides a route to reviewing indexed publications and associated citation records. Affiliation details, author-name variants, and profile metrics may change over time; institutional and database records should therefore be consulted for current verification. [2]

Research Contributions

The identified clinical trial addresses two components of smoking-related care: carbon monoxide assessment and brief anti-smoking advice. Its focus on kidney transplant recipients places the investigation within a specialized clinical population. The study title indicates a randomized trial design, although detailed conclusions, sample characteristics, and outcome estimates should be drawn from the full publication rather than inferred from bibliographic metadata alone. [1]

Publications

The supplied record identifies the following publication:

  • “Randomized clinical trial to determine the effectiveness of CO-oximetry and anti-smoking brief advice in a cohort of kidney transplant patients who smoke.” International Journal of Medical Sciences, 2020. The supplied record lists Mercedes Cao Vilariño among the authors. [1]

Research Impact

The supplied indicators report five documents, 15 citations, and an h-index of three. Citation counts offer one measure of scholarly visibility, but they do not independently establish research quality, clinical effectiveness, or societal benefit. A fuller assessment would consider study design, methodological rigor, reproducibility, collaboration, and relevance to patient care. These indicators should be checked against the current Scopus record before formal publication. [2]

Award Suitability

The Research Excellence Award profile highlights a documented contribution to clinical research relevant to tobacco cessation and transplant care. Consideration for recognition may include verified publications, methodological contributions, independent evidence of impact, and the candidate’s wider research record. This profile describes award-related recognition context and does not, by itself, confirm that an award has been formally conferred.

Conclusion

Mercedes Cao Vilariño’s supplied research profile includes a clinical publication on smoking-related intervention in kidney transplant patients. The reported bibliometric indicators offer a concise snapshot of scholarly activity, while a complete evaluation requires examination of the publication, current author records, and broader evidence of research contribution. Accurate attribution and transparent verification remain essential to responsible academic recognition.

References

  1. Seijo-Bestilleiro, R., Seoane-Pillado, M. T., Pértega-Díaz, S. D., Cao Vilariño, M., Gil-Guillén, V. F., et al. (2020). Randomized clinical trial to determine the effectiveness of CO-oximetry and anti-smoking brief advice in a cohort of kidney transplant patients who smoke.
  2. Elsevier. (n.d.). Scopus author details: Mercedes Cao Vilariño, Author ID 57195055799. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57195055799
  3. International Journal of Medical Sciences. (2020). Journal publication record for the randomized clinical trial on CO-oximetry and smoking cessation advice in kidney transplant patients.
  4. Global Innovation Technologist Awards. (n.d.). Official awards website.
    innovationtechnologist.com/

Daniel Alfaiate | Medicine and Health Sciences | Best Researcher Award

Published on by Innovation Technologist

Best Researcher Award

Daniel Alfaiate
Instituto Politécnico de Castelo Branco, Portugal

Daniel Alfaiate
Affiliation Instituto Politécnico de Castelo Branco
Country Portugal
Scopus ID 58158006300
Documents 3
Citations 31
h-index 2
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards
ORCID 0000-0002-5581-4242

Daniel Alfaiate is a researcher affiliated with the Instituto Politécnico de Castelo Branco whose documented scholarly activity is situated within Medicine and Health Sciences. The available publication record includes research concerning sleep medicine, obstructive sleep apnea (OSA), electroencephalography, hematological outcomes, and psychotropic medication effects on sleep architecture. Bibliographic information identifies three Scopus documents and 31 citations, with a reported h-index of 2.

Abstract

The research profile of Daniel Alfaiate reflects an emerging focus on clinical and physiological dimensions of sleep and neurological assessment. His documented works address OSA, wakefulness electroencephalography, hematocrit and erythrocytosis, and the effects of psychotropic medication on sleep architecture. These subjects connect diagnostic assessment with clinically relevant sleep outcomes and provide a coherent basis for evaluating research activity in Medicine and Health Sciences. [1]

Keywords

Sleep medicine; obstructive sleep apnea; electroencephalography; polysomnography; sleep architecture; psychotropic medication; hematocrit; erythrocytosis; clinical research.

Introduction

Sleep disorders can involve respiratory, neurological, cardiovascular, and behavioral dimensions, making multidisciplinary clinical research particularly relevant. OSA is associated with measurable physiological changes and may require complementary diagnostic approaches. Research examining wakefulness EEG and hematological characteristics contributes to the broader clinical understanding of patients evaluated for sleep-related disorders. [2] [3]

Research Profile

The available record indicates a focused research trajectory around sleep-related clinical investigation. The profile combines observational clinical work with physiological measurement, including polysomnographic assessment and electroencephalographic evaluation. Bibliometric indicators reported for the researcher include three documents, 31 citations, and an h-index of 2. [1]

Research Contributions

The documented publications address complementary aspects of sleep-related medicine. One study examines the relationship between OSA and hematocrit or erythrocytosis, while another evaluates wakefulness EEG in OSA patients. A later article investigates class-specific and cumulative effects of psychotropic medication on sleep architecture using retrospective polysomnographic data. [2] [3] [4]

Publications

  • Class-specific and cumulative effects of psychotropic medication on sleep architecture: a polysomnographic retrospective study. European Journal of Pharmacology, 2026. [4]
  • Impact of obstructive sleep apnea on hematocrit levels and erythrocytosis – a clinical study. Sleep and Breathing, 2025. [2]
  • Evaluation of wakefulness electroencephalogram in OSA patients. Sleep and Breathing, 2024. [3]
  • Evaluation of wakefulness electroencephalogram in OSA patients. Research Square, 2024. [5]
  • O Eletroencefalograma Emergente nos Cuidados Intensivos. Repositório Científico do Instituto Politécnico de Castelo Branco, 2023. [6]

Research Impact

The reported bibliometric record of 31 citations and an h-index of 2 provides a measurable indication of scholarly visibility. The publications also demonstrate continuity in sleep-related research across 2023–2026, with topics spanning intensive care, OSA assessment, hematological outcomes, and medication-associated changes in sleep architecture. [1]

Award Suitability

For the Best Researcher Award category, the documented record provides evidence of peer-reviewed research activity in a defined medical research area. The combination of recent journal publications, sleep-medicine investigations, and identifiable bibliometric indicators offers an objective basis for consideration. Award assessment should additionally consider authorship roles, methodological quality, peer-review status, broader collaboration, and independent verification of bibliographic records.

Conclusion

Daniel Alfaiate’s documented research activity centers on clinically relevant questions in sleep and neurological assessment. His publications provide a coherent research profile involving OSA, EEG evaluation, hematological outcomes, and polysomnographic investigation. The available bibliometric and publication evidence supports consideration within an academic recognition framework, subject to standard verification procedures.

References

  1. Elsevier. (n.d.). Scopus author details: Daniel Alfaiate, Author ID 58158006300. Scopus.
    https://www.scopus.com/pages/authors/58158006300
  2. Springer Nature. (2025). Impact of obstructive sleep apnea on hematocrit levels and erythrocytosis – a clinical study. Sleep and Breathing.
    DOI: 10.1007/s11325-025-03330-2
  3. Springer Nature. (2024). Evaluation of wakefulness electroencephalogram in OSA patients. Sleep and Breathing.
    DOI: 10.1007/s11325-024-03116-y
  4. Elsevier. (2026). Class-specific and cumulative effects of psychotropic medication on sleep architecture: a polysomnographic retrospective study. European Journal of Pharmacology.
    DOI: 10.1016/j.ejphar.2026.179292
  5. Research Square. (2024). Evaluation of wakefulness electroencephalogram in OSA patients.
    DOI: 10.21203/rs.3.rs-3831506/v1
  6. Instituto Politécnico de Castelo Branco. (2023). O Eletroencefalograma Emergente nos Cuidados Intensivos. Repositório Científico do Instituto Politécnico de Castelo Branco.

Laura Moreno Galarraga | Health Professions | Excellence in Research Award

Published on by Innovation Technologist

Assoc. Prof. Dr. Laura Moreno Galarraga | Health Professions | Excellence in Research Award

Pediatrician at University Hospital of Navarre | Spain

Dr. Laura Moreno Galarraga is an accomplished pediatrician and academic specializing in pediatric pulmonology with extensive experience in both clinical practice and research. She earned her medical degree from the University of Navarra and completed her specialization in pediatrics at Virgen de las Nieves Hospital in Granada, followed by a Ph.D. in Medicine from the University of Granada. She has served as an Assistant Professor at the University of Navarra and later at the Public University of Navarra, contributing significantly to the fields of preventive medicine and child health. As a pediatric pulmonologist at the University Hospital of Navarra, she has developed expertise in respiratory disorders in children and has been accredited by the Spanish Association of Pediatrics. Dr. Moreno Galarraga leads the Preventive Pediatric Research Group at the Navarra Health Research Institute and coordinates the SENDO Pediatric Cohort Study. Her research focuses on preventive pediatrics, respiratory health, and the early determinants of childhood diseases. She has collaborated in multiple national and international clinical trials, including projects on influenza vaccination, respiratory infections, and vaccine immunogenicity. Her scholarly output includes numerous publications in peer-reviewed journals addressing pediatric asthma management, COVID-19, and cystic fibrosis. She is actively engaged in professional societies such as the Spanish Association of Pediatrics, the Spanish Society of Pediatric Pulmonology, and the European Respiratory Society, where she contributes to education and research initiatives on childhood respiratory health. Her dedication to pediatric research and medical education continues to influence preventive pediatric healthcare practices in Spain and beyond.

Profile: Orcid

Featured Publications

Moreno-Galarraga, L., Escrivá, N., Barado, E., Torres, M. G., & Fernandez-Montero, A. (2025). Association between acute COVID‐19 infection and long COVID in a non‐hospitalized population: A retrospective case‐control study. Health Science Reports, 8(8), e71043.

Erroz Ferrer, M., Paniagua García, M., Viguria Sánchez, N., & Moreno-Galarraga, L. (2025, August 20). The role of biologic therapy switching to optimize the treatment of severe pediatric asthma: Tezepelumab is a new therapeutic alternative for adolescents. Children, 12(8), 1092.

Moreno-Galarraga, L., García Vera, C., Rivero-Calle, I., Martinón-Torres, F., Díez López, I., Cabañas, F., & Calvo, C. (2025, July). Investigación pediátrica en España: desafíos y oportunidades. Anales de Pediatría, 103(7), 503854.

Garcia Gerriko, J., Simoneau, T., Gaffin, J. M., Ortúzar Menéndez, M., Fernandez-Montero, A., & Moreno-Galarraga, L. (2025, June). Impact of telemedicine on asthma control and quality of life in children and adolescents: A systematic review and meta-analysis. Children, 12(7), 849.

Chaverri Repáraz, C. M., Lacalle Fabo, E., Erroz Ferrer, M., Gimeno-Castillo, M., Castro-Garrido, I., Ibarzabal-Arregi, M., González Arza, N., Viguria, N., & Moreno-Galarraga, L. (2025, January). Tailoring biologic therapies for pediatric severe asthma: A comprehensive approach. Children, 12(2), 140.

Jatinder Kumar | Health Care Services | Best Researcher Award

Published on by Innovation Technologist

Dr. Jatinder Kumar | Health Care Services | Best Researcher Award

IT Professional at PGIMER, Chandigarh, India

Dynamic IT professional with over 25 years of experience in software development, network infrastructure, and IT solutions. Specializes in full-stack development, cloud computing (AWS, Azure), network security, and virtualization technologies. Experienced in integrating business strategy with technology to enhance IT operations. Holds extensive expertise in hospital information systems, data analytics, and artificial intelligence applications in healthcare.

Publication Profile 

Scopus

Educational Background 🎓

  • PhD in Computer Science, Chitkara University (2024)
  • Master of Philosophy (Computer Science), MMU, Sadopur, Ambala, Haryana (2013)
  • Master of Business Administration (MBA), Panjab University, Chandigarh (2006)
  • Master of Computer Applications (MCA), Panjab University, Chandigarh (1997)
  • Bachelor of Science (B.Sc.), M.A.M. College, Jammu (1994)

Professional Experience 💼

  • Software Engineer, Trident InfoTech Corporation Limited, Chandigarh
    • Developed software solutions and contributed to system design and deployment.
    • Worked on enterprise-level applications for various industries.
  • Computer Programmer, PGIMER, Chandigarh (Since 2001)
    • Key contributor to the implementation of the Hospital Information System (HIS) for a 2,500-bed hospital.
    • Designed and developed the inventory module using process flow diagrams and entity-relationship diagrams.
    • Enhanced patient care, reduced wait times, and streamlined administrative workflows.
    • Involved in system integration, cloud-based solutions, and data migration strategies.

Research Interests 🔬

  • Artificial intelligence and deep learning applications in healthcare.
  • Medical imaging and thyroid nodule analysis using deep learning models.
  • Multi-agent system frameworks for efficient hospital administration.
  • Cloud computing and security solutions for healthcare IT systems.
  • e-Governance and digital transformation in public healthcare.

Awards and Honors🏆✨

  • Best Paper Presentation, TELEMEDICON 2024, PGIMER, Chandigarh.
  • Best Paper Presentation, ICAAIML 2024, Hyderabad, India.
  • First Prize in Yoga Competition, International Yoga Day 2024, PGIMER, Chandigarh.
  • Represented Chandigarh in National Yoga Competitions in Telangana and Rajasthan.
  • Conducting yoga classes and educational support for underprivileged children in Chandigarh.
  • Various professional certifications in hardware, Oracle, and MCSE.

Conclusion🌟

With an extensive background in IT, healthcare systems, and artificial intelligence, the author has made significant contributions to hospital information systems and deep learning applications in medical imaging. His research and professional work have enhanced patient care and operational efficiency in healthcare institutions. Recognized for academic excellence and community service, he continues to drive innovation in AI-driven healthcare solutions and IT infrastructure development.

Publications 📚

📖 Kumar, J., Panda, S.N., & Dayal, D. (2023, December). Deep Learning for Improved Thyroid Nodule Analysis in Ultrasound Images. INTERNATIONAL JOURNAL OF RESEARCH AND ANALYTICAL REVIEWS (IJRAR.ORG), Volume 10, Issue 4.

📖 Kumar, J., Panda, S.N., & Dayal, D. (2023). Utilizing Deep Learning Models for the Classification of Thyroid Nodules in Ultrasound Images. The International Journal of Engineering and Science (IJES), Volume 12, Issue 11, Pages 18-31.

📖 Kumar, J., Panda, S.N., & Dayal, D. (2023, December). An Overview of Deep Learning Methods for Segmenting Thyroid Ultrasound Images. International Journal of Advanced Engineering and Nano Technology (IJAENT), ISSN: 2347-6389 (Online), Volume 10, Issue 12.

📖 Kumar, J., Panda, S.N., Dayal, D., & Sharma, M. (2024). Enhancing Thyroid Nodule Assessment with Deep Learning and Ultrasound Imaging. e-Prime – Advances in Electrical Engineering, Electronics, and Energy (Scopus). (Submitted after revision, awaiting acceptance letter.)

🎙️ Kumar, J., Panda, S.N., & Dayal, D. (2023, November). Deep learning routes to thyroid ultrasound image segmentation: A review. AIP Conference Proceedings, Vol. 2878, No. 1. AIP Publishing.

🎙️ Kumar, J., Panda, S.N., Dayal, D., & Sharma, M. (2023, September). Review of Deep Learning Techniques Over Thyroid Ultrasound Image Segmentation. 2023 International Conference on Sustainable Emerging Innovations in Engineering and Technology (ICSEIET), pp. 320-326. IEEE.

🎙️ Kumar, J., Panda, S.N., & Dayal, D. (2023). Pediatric Thyroid Ultrasound Image Classification Using Deep Learning: A Review. Chitkara University Doctoral Consortium – CUDC 2023.

🎙️ Kumar, J., Panda, S.N., & Dayal, D. (2024). Improving Thyroid Nodule Evaluation Using Deep Learning and Ultrasound Imaging. National Telemedicine Conference – TELEMEDICON 2024, held in Chandigarh (November 28-30, 2024).